Short answer
XOMA Royalty Corp (XOMA) filed its Q1 2026 10-Q quarterly report on May 12, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $12M (down 22.6% year over year) with net income of $4M.
Q1 2026 key financials · XBRL
- Revenue
- $12M
- −22.6% YoY
- Net income
- $4M
- +88.6% YoY
- Operating margin
- -3.9%
- EPS (diluted)
- $0.17
- +183.3% YoY
Source: XBRL data from the XOMA Royalty Corp (XOMA) Q1 2026 10-Q on SEC EDGAR. USD.
XOMA Royalty Corp Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue, YoY change, margins, segment performance, and net income not provided
- Cash position, operating cash flow, and capital deployment not provided
- Outlook: potential VABYSMO and OJEMDA income, proposed Ligand merger, royalty and milestone uncertainty
- Headwinds: regulatory, development funding, macroeconomic, inflation, interest rates, tariffs, and geopolitical risks
Risk Factors
- New merger-completion risk triggered by April 27, 2026 Ligand agreement, requiring stockholder and regulatory approvals
- Regulatory risk from HSR Act review, including potential divestitures, business restrictions, or imposed transaction costs
- Financial risk of $40.0 million termination fee if specified merger conditions or alternative-proposal events occur
- Operational risk from merger restrictions limiting indebtedness, acquisitions, asset sales, contracts, and capital expenditures
- Liquidity risk if merger fails, potentially requiring capital raising amid uncertain market access and increased insolvency risk
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other XOMA Royalty Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.